Alisa Kabcenell
Boehringer Ingelheim
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alisa Kabcenell.
Journal of Biological Chemistry | 2007
Ayala Luria; Steven M. Weldon; Alisa Kabcenell; Richard H. Ingraham; Damian Matera; Huiping Jiang; Rajan Gill; Christophe Morisseau; John W. Newman; Bruce D. Hammock
Arachidonic acid-derived epoxides, epoxyeicosatrienoic acids, are important regulators of vascular homeostasis and inflammation, and therefore manipulation of their levels is a potentially useful pharmacological strategy. Soluble epoxide hydrolase converts epoxyeicosatrienoic acids to their corresponding diols, dihydroxyeicosatrienoic acids, modifying or eliminating the function of these oxylipins. To better understand the phenotypic impact of Ephx2 disruption, two independently derived colonies of soluble epoxide hydrolase-null mice were compared. We examined this genotype evaluating protein expression, biofluid oxylipin profile, tissue oxylipin production capacity, and blood pressure. Ephx2 gene disruption eliminated soluble epoxide hydrolase protein expression and activity in liver, kidney, and heart from each colony. Plasma levels of epoxy fatty acids were increased, and fatty acid diols levels were decreased, while measured levels of lipoxygenase- and cyclooxygenase-dependent oxylipins were unchanged. Liver and kidney homogenates also show elevated epoxide fatty acids. However, in whole kidney homogenate a 4-fold increase in the formation of 20-hydroxyeicosatetraenoic acid was measured along with a 3-fold increase in lipoxygenase-derived hydroxylation and prostanoid production. Unlike previous reports, however, neither Ephx2-null colony showed alterations in basal blood pressure. Finally, the soluble epoxide hydrolase-null mice show a survival advantage following acute systemic inflammation. The data suggest that blood pressure homeostasis may be achieved by increasing production of the vasoconstrictor, 20-hydroxyeicosatetraenoic acid in the kidney of the Ephx2-null mice. This shift in renal metabolism is likely a metabolic compensation for the loss of the soluble epoxide hydrolase gene.
FEBS Letters | 1993
Michelle D. Garrett; Alisa Kabcenell; Joseph E. Zahner; Kozo Kaibuchi; Takuya Sasaki; Yoshimi Takai; Clarissa M. Cheney; Peter Novick
Rab GDP dissociation inhibitor (Rab GDI), will induce the dissociation of GDP‐bound rab3A from synaptic membranes and will inhibit GDP dissociation from Sec4, a member of the Rab subgroup of the Ras GTPase superfamily which is required for exocytosis in Saccharomyces cerevisiae. We report that Rab GDI releases GDP‐bound Sec4 from yeast membranes. dGDI, a Drosophila homologue can similarly inhibit GDP dissociation from Sec4 and release GDP‐bound Sec4 from yeast membranes. An activity partially purified from yeast cytosol dissociates GDP‐bound Sec4 from yeast membranes, suggesting that yeast also possess a GDI protein that functions to recycle Sec4 from its target membrane.
Journal of Pharmacological and Toxicological Methods | 2001
Earvin Liang; Alisa Kabcenell; James R. Coleman; John A. Robson; Royal Ruffles; Mehran Yazdanian
INTRODUCTION M cells are located in the epithelial layer covering the gut-associated lymphoid tissue and are responsible for delivery of macromolecules and microorganisms to the underlying lymphoid cells. It has been shown that the human colonic cell line Caco-2 can be converted to M cells in vitro following coculture with isolated lymphocytes from murine Peyers patches. Studies were undertaken to evaluate and characterize the transepithelial transport of select macromolecules across these in vitro derived M cells. METHODS Caco-2 cells were converted to M cells as reported previously. The morphology of Caco-2 cells and M cells was compared by transmission electron microscopy (TEM). The transport properties of macromolecules such as horseradish peroxidase, FITC-conjugated polystyrene beads, and radiolabeled dextrans were examined. The activation of murine antigen-specific T cells following transport of the antigen ovalbumin across the M-cell barrier was assessed by measuring cytokine production. RESULTS M cells were shown to be irregular in shape and have fewer and shorter microvilli compared to the Caco-2 cell progenitors. These cells were still able to form tight junctions and monolayers on polycarbonate membranes. Time-course studies demonstrated that the transport of polystyrene beads and large-molecular-weight dextrans at physiological temperature across M-cell-containing monolayers was size dependent and more rapid than across Caco-2 cell monolayers. The transport of dextrans was also shown to be temperature and concentration dependent. Befitting the role of the M cell in mucosal defense, protein antigen could be delivered by these cells in order to be processed and presented to antigen-specific CD4+ T lymphocytes. DISCUSSION The M-cell permeability model is a functional and practical system for evaluating the transport properties of macromolecules and assessing the potential for intestinal mucosal antigen sampling to elicit immunological responses.
Bioorganic & Medicinal Chemistry Letters | 2010
Ho Yin Lo; Chuk Chui Man; Roman Wolfgang Fleck; Neil A. Farrow; Richard H. Ingraham; Alison Kukulka; John R. Proudfoot; Raj Betageri; Tom Kirrane; Usha R. Patel; Rajiv Sharma; Mary Ann Hoermann; Alisa Kabcenell; Stephane De Lombaert
A novel series of pyrazole sEH inhibitors is reported. Lead optimization efforts to replace the aniline core are also described. In particular, 2-pyridine, 3-pyridine and pyridazine analogs are potent sEH inhibitors with favorable CYP3A4 inhibitory and microsomal stability profiles.
Bioorganic & Medicinal Chemistry Letters | 2009
Steven John Taylor; Fariba Soleymanzadeh; Anne Bettina Eldrup; Neil A. Farrow; Ingo Muegge; Alison Kukulka; Alisa Kabcenell; Stephane De Lombaert
A series of potent nicotinamide inhibitors of soluble epoxides hydrolase (sEH) is disclosed. This series was designed using structure-based deconstruction and a combination of two HTS hit series, resulting in hybrid analogs that retained the optimal potency from one series, and acceptable in vitro metabolic stability from the other. Structure-guided optimization of these analogs gave rise to nanomolar inhibitors of human sEH that had acceptable plasma exposure to qualify them as probes to determine the in vivo phenotypic consequences of sEH inhibition.
Cytometry Part A | 2003
Daniel Rajotte; Carol D. Stearns; Alisa Kabcenell
Mast cells are specialized secretory cells of the immune system. Through exocytosis of their secretory lysosomes and secretory granules, mast cells release biologically active substances such as histamine and proteases. Mast cell secretory granules have been studied extensively but much less attention has been given to secretory lysosomes. Studies on mast cell secretory lysosomes are limited by the lack of selective markers and the difficulty to isolate this organelle from conventional lysosomes. Our goal was to develop better tools to study secretory lysosomes.
Journal of Biomolecular Screening | 2006
E. Michael August; Lori Patnaude; Jerry L. Hopkins; Joey M. Studts; Elda Gautschi; Anthony Shrutkowski; Anthony Kronkaitis; Martha Priscilla Brown; Alisa Kabcenell; Daniel Rajotte
Histamine is a well-known mediator of allergic, inflammatory, and neurological responses. More recent studies suggest a role for histamine and its receptors in a wide range of biological processes, including T-cell maturation and bone remodeling. Histamine serum levels are regulated mainly by the activity of the histamine-synthesizing enzyme histidine decarboxylase (HDC). Despite the importance of this enzyme in many physiological processes, very few potent HDC inhibitors have been identified. HDC assays suitable for high-throughput screening have not been reported. The authors describe the development of a fluorescence polarization assay to measure HDC enzymatic activity. They used a fluorescein-histamine probe that binds with high affinity to an antihistamine antibody for detection. Importantly, they show that probe binding is fully competed by histamine, but no competition by the HDC substrate histidine was observed. The automated assay was performed in a total volume of 60 μL, had an assay window of 80 to 100 mP, and had a Z′ factor of 0.6 to 0.7. This assay provides new tools to study HDC activity and pharmacological modulation of histamine levels.
Journal of Medicinal Chemistry | 1999
Pierre L. Beaulieu; Dale R. Cameron; Ferland Jm; Jean Gauthier; Elise Ghiro; James Gillard; Gorys; Martin Poirier; Jean Rancourt; Dominik Wernic; Montse Llinas-Brunet; Rajashehar Betageri; Mario G. Cardozo; Eugene R. Hickey; R. H. Ingraham; Scott Jakes; Alisa Kabcenell; Thomas M. Kirrane; Susan Lukas; Usha R. Patel; John R. Proudfoot; Rajiv Sharma; Liang Tong; Neil Moss
Journal of Medicinal Chemistry | 2001
John R. Proudfoot; Rajashehar Betageri; Mario G. Cardozo; Thomas A. Gilmore; Susan L. Glynn; Eugene R. Hickey; Scott Jakes; Alisa Kabcenell; Thomas M. Kirrane; Annette K. Tibolla; Susan Lukas; Usha R. Patel; Rajiv Sharma; Mehran Yazdanian; Neil Moss; Pierre L. Beaulieu; Dale R. Cameron; Jean-Marie Ferland; Jean Gauthier; James Gillard; Vida Gorys; Martin Poirier; Jean Rancourt; Dominik Wernic; Montse Llinas-Brunet
Archive | 2003
Daniel Rajotte; Alisa Kabcenell